Stock of Caredx Inc (CDNA) performance and profitability takes another direction

Currently, Caredx Inc [CDNA] is trading at $9.18, up 18.30%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CDNA shares have gain 15.04% over the last week, with a monthly amount drifted -7.74%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on May 01, 2024, when Craig Hallum upgraded its rating to a Buy but kept the price target unchanged to $15 for it. Previously, Stephens upgraded its rating to Overweight on November 09, 2023, and kept the price target unchanged to $10. On August 15, 2023, upgrade upgraded it’s rating to Outperform but maintained its price target of $12 on the stock. BTIG Research downgraded its rating to a Neutral. Stephens downgraded its rating to a Equal-Weight and reduced its price target to $9 on March 07, 2023. Raymond James downgraded its rating to Mkt Perform for this stock on March 03, 2023. In a note dated March 03, 2023, Craig Hallum downgraded an Hold rating on this stock and revised its target price from $26 to $9.

This stock has fluctuated between a low of $4.80 and a high of $12.93 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $9.18 at the most recent close of the market. An investor can expect a potential return of 139.65% based on the average CDNA price forecast.

Analyzing the CDNA fundamentals

Trailing Twelve Months sales for Caredx Inc [NASDAQ:CDNA] were 280.32M which represents -20.41% decline. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.37%, Pretax Profit Margin comes in at -0.68%, and Net Profit Margin reading is -0.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.51 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.42 points at the first support level, and at 7.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.95, and for the 2nd resistance point, it is at 10.72.

Caredx Inc [CDNA] reported earnings per share of -$0.17 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.27/share, meaning a difference of $0.1 and a surprise factor of 37.00%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.18 per share as compared to estimates of -$0.39 per share, a difference of $0.21 representing a surprise of 53.80%.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Caredx Inc [NASDAQ:CDNA] is 4.02. In addition, the Quick Ratio stands at 3.77 and the Cash Ratio stands at 1.05. Considering the valuation of this stock, the price to sales ratio is 1.70, the price to book ratio is 1.81.

Transactions by insiders

Recent insider trading involved Seeto Reginald,, that happened on Oct 02 ’23 when 2818.0 shares were sold., Seeto Reginald completed a deal on Sep 05 ’23 to sell 2819.0 shares. Meanwhile, Seeto Reginald sold 576.0 shares on Aug 14 ’23.

Related Posts